Among both CCR7 ligands, CCL21 is of particular interest in our cohort because it is not only involved in the homing of cells to the endothelial venules in lymph nodes, thus alleviating leucocytic transmembrane trafficking, but it is also a putative marker of cardiovascular disease [10]. Here, CCL21 is linked to cardiovascular disorder.